The global gastrointestinal endoscopy devices market was valued at US$ 45.6 Billion in 2022, and is projected to reach US$ 81.0 Billion by 2030, growing at a CAGR of 7.5% from 2023 to 2030. The global gastrointestinal endoscopy device market refers to the market for medical devices used to perform endoscopic procedures in the gastrointestinal (GI) tract. These procedures involve inserting an endoscope into the GI tract to examine, diagnose, and treat various conditions affecting the digestive system.

Browse 215 market data Tables and 96 Figures spread through 312 Pages and in-depth TOC on "Gastrointestinal Endoscopy Device Market Size, Share & Trends Estimation Report By Outlook, By Region, And Segment Forecasts, 2022 - 2030" View detailed Table of Content here-https://www.contrivedatuminsights.com/product-report/gastrointestinal-endoscopy-device-market-248621/

The market for gastrointestinal endoscopy devices is driven by the increasing prevalence of digestive disorders, such as gastroesophageal reflux disease (GERD), inflammatory bowel disease (IBD), and colorectal cancer, as well as the growing aging population. Technological advancements in endoscopy devices, such as the development of capsule endoscopy and virtual endoscopy, have also contributed to the growth of this market.

Market Dynamics

The rising incidence of digestive disorders, such as GERD, IBD, and colorectal cancer, is a major driver of the gastrointestinal endoscopy device market. Endoscopy is a crucial tool for the diagnosis and treatment of these conditions, which has led to a surge in demand for endoscopic devices. As the global population ages, the incidence of digestive disorders increases, further driving the demand for gastrointestinal endoscopy devices. Older individuals are more likely to develop conditions such as colorectal cancer, and endoscopy is an effective way to detect and treat these conditions.

Endoscopic procedures can be expensive, which may limit their accessibility for some patients. In some countries, the cost of these procedures is not fully covered by insurance, which can be a barrier to adoption. Although endoscopy is a minimally invasive procedure, there is still a risk of complications, such as bleeding or perforation. This risk can be a concern for both patients and healthcare providers, which may limit the adoption of endoscopic procedures.

The market for gastrointestinal endoscopy devices is highly competitive, with many established players and new entrants vying for market share. This can make it difficult for manufacturers to differentiate their products and gain a foothold in the market. The regulatory landscape for gastrointestinal endoscopy devices is becoming increasingly complex, with more stringent regulations and greater scrutiny of safety and efficacy. This can lead to delays in product development and commercialization, and can increase the cost of bringing new products to market.

EUS devices are used for the diagnosis and treatment of gastrointestinal diseases by providing high-quality images of the gastrointestinal tract and surrounding tissues. This segment can be further divided into radial EUS, linear EUS, and forward-viewing EUS. Biopsy devices are used to collect tissue samples from the gastrointestinal tract for pathological analysis. This segment can be further divided into forceps, needles, and brushes. ERCP devices are used for the diagnosis and treatment of diseases of the bile and pancreatic ducts. This segment can be further divided into duodenoscopes, sphincterotomes, and stents.

Ambulatory surgical centers are gaining popularity as they offer cost-effective outpatient services compared to hospitals. As a result, the demand for gastrointestinal endoscopy devices is increasing in ASCs. Gastrointestinal endoscopy devices are also used in clinics for the diagnosis and treatment of various gastrointestinal disorders. Clinics are usually preferred for routine check-ups and minor procedures.

Diagnostic centers are facilities that specialize in diagnostic testing and imaging. They use gastrointestinal endoscopy devices for the diagnosis of gastrointestinal disorders. Other end-use segments for gastrointestinal endoscopy devices include research laboratories, academic institutions, and medical camps.

The hospitals segment dominates the global gastrointestinal endoscopy device market, followed by ASCs and clinics. The increasing prevalence of gastrointestinal diseases, such as colorectal cancer, is driving the demand for gastrointestinal endoscopy devices in all end-use segments. Additionally, advancements in technology and the introduction of innovative products are expected to drive market growth in the coming years.

Regional Analysis

North America and Europe are the largest markets for gastrointestinal endoscopy devices, with Asia Pacific expected to exhibit the highest growth rate due to the increasing adoption of endoscopy procedures in emerging economies such as China and India. Key players in the market include Olympus Corporation, Boston Scientific Corporation, Fujifilm Holdings Corporation, and Medtronic plc.

The European market for gastrointestinal endoscopy devices is also mature, with strong demand for diagnostic and therapeutic procedures. The market is fragmented, with many small and medium-sized manufacturers competing with larger multinational corporations. The Asia-Pacific region is expected to be the fastest-growing market for gastrointestinal endoscopy devices, driven by a large patient population, increasing healthcare spending, and growing demand for minimally invasive procedures. China, Japan, and India are the largest markets in the region.

Competitive Analysis

Medtronic plc is a global healthcare company that offers a range of endoscopy devices for gastrointestinal procedures, including both diagnostic and therapeutic devices. Boston Scientific Corporation is a leading manufacturer of medical devices, including gastrointestinal endoscopy devices for both diagnostic and therapeutic procedures.

Cook Medical LLC is a medical device company that offers a range of gastrointestinal endoscopy devices, including biopsy forceps, retrieval devices, and stents. Karl Storz GmbH & Co. KG is a leading manufacturer of endoscopy devices for gastrointestinal procedures, offering a range of diagnostic and therapeutic devices.

Boston Scientific Corporation acquired Creo Medical Group plc in March 2021 for $510 million, expanding its product offerings in the field of advanced endoscopy.

Olympus Corporation announced in May 2021 that it was selling its medical business to Japan Industrial Partners Inc. for $1.7 billion, including its gastrointestinal endoscopy business.

Fujifilm Holdings Corporation announced in February 2021 that it was acquiring a majority stake in medwork GmbH, a Germany-based medical technology company that specializes in gastrointestinal endoscopy.

Cook Medical LLC announced in October 2020 that it was acquiring the endoscopy business of Zeiss Group, a German optical systems manufacturer, to expand its product offerings in the field of advanced endoscopy.

Medtronic plc announced in July 2020 that it was investing $40 million in Atlantic Therapeutics Group Ltd., a company that develops non-invasive pelvic floor muscle strengthening devices for urinary and fecal incontinence.

Segmentation Analysis of The Global Gastrointestinal Endoscopy Device Market 2016-2030

The report forecasts revenue growth at global, regional, and country matrics and analyzes the latest industry trends in each of the sub-segments ranging from 2016-2030. For this, CDI has segmented the global gastrointestinal endoscopy market report based on capacity, vehicle, application, and propulsion type along with regional analysis. 

Product Outlook (Volume, Units; Capacity, Mega Watt; Revenue, USD Million, 2016 - 2028)

• GI Videoscopes
• Biopsy Devices
• Endoscopic Retrograde Cholangiopancreatography Devices (ERCP)
• Capsule Endoscopy
• Endoscopic Ultrasound
• Endoscopic Mucosal Resection (EMR)
• Hemostasis Devices
• Other Product Types

Sales Channel Outlook (Volume, Units; Capacity, Mega Watt; Revenue, USD Million, 2016 - 2028)

• Online Retailing
• Medical Stores & Brand Outlet

End Outlook (Volume, Units; Capacity, Mega Watt; Revenue, USD Million, 2016 - 2028)

• Hospitals, 
• Clinics & Dialysis Centers
• Ambulatory Surgical Center

Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
• Germany
• France
• Italy
• Spain
• UK
• Nordic Countries
• Denmark
• Finland
• Iceland
• Sweden
• Norway
• Benelux Union
• Belgium
• The Netherlands
• Luxembourg
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• Australia
• South Korea
• Southeast Asia
• Indonesia
• Thailand
• Malaysia
• Singapore
• Rest of Southeast Asia
• Rest of Asia-Pacific
• The Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East & Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America